Search results
Results from the WOW.Com Content Network
After this discussion, men who want to be screened should get the prostate-specific antigen (PSA) blood test. The digital rectal exam (DRE) may also be done as a part of screening. (See Screening Tests for Prostate Cancer.)
PSA-based screening for prostate cancer has been studied in 3 very large RCTs, each with at least a decade of median follow-up: the US-based Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, the European Randomized Study of Screening for Prostate Cancer (ERSPC), and the Cluster Randomized Trial of PSA Testing for Prostate ...
The guideline provides detailed recommendations for clinicians concerning the core factors related to prostate cancer screening and treatment that should be shared with men to enable them to make a truly informed decision regarding whether to be screened.
Some men get a PSA test to screen for prostate cancer. Talk to your doctor, learn what is involved, and decide if a PSA test is right for you. Cancer screening means looking for cancer before it causes symptoms.
After a median follow-up of 3.9 years (approximately 26,000 person-years in each group), prostate cancer had been detected in 185 of the 6575 men (2.8%) in the MRI-targeted biopsy group and 298 of ...
PSA screening involves weighing the benefits of reducing the rate of metastatic prostate cancer and prevention of prostate cancer death against the known potential harms associated with screening and treatment.
Screening for prostate cancer is done with a simple blood test called a prostate-specific antigen (PSA) test. This test measures the level of a protein made by cells in the prostate gland in your blood. PSA levels rise if there’s a problem with your prostate. It’s normal to have a low level of PSA.
Benefits of Early Detection and Treatment. The goal of screening for prostate cancer is to identify high-risk, localized prostate cancer that can be successfully treated, thereby preventing the morbidity and mortality associated with advanced or metastatic prostate cancer.
Prostate Cancer: Screening. An Update for This Topic is In Progress. LAST UPDATED: Dec 21, 2023. The Task Force keeps recommendations as current as possible by routinely updating existing recommendations and developing new recommendations. A multistep process is followed for each recommendation.
In 2018, the United States Preventive Serves Task Force (USPSTF) updated its recommendation statement for prostate cancer screening from a “D” (not recommended) to a “C” (selectively offering PSA-based screening based on professional judgment and patient preferences) in men ages 55 to 69.